{"id":1643,"date":"2014-12-26T18:03:24","date_gmt":"2014-12-26T09:03:24","guid":{"rendered":"http:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/?page_id=1643"},"modified":"2014-12-26T18:03:24","modified_gmt":"2014-12-26T09:03:24","slug":"2008-2","status":"publish","type":"page","link":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/2008-2\/","title":{"rendered":"2008"},"content":{"rendered":"

2008<\/h2>\n
    \n
  1. Ishino S, Mukai T, Kuge Y, Kume N, Ogawa M, Takai N, Kamihashi J, Shiomi M, Minami M, Kita T, Saji H.
    \nlectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with\u00a099m<\/sup>Tc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque.
    \nJ. Nucl. Med.<\/i>\u00a049<\/strong>\u00a0(10) 1677-1685 (2008)<\/li>\n
  2. Doue T, Ohtsuki K, Ogawa K, Ueda M, Azuma A, Saji H, Strauss H. W, Matsubara H.
    \nCardioprotective effects of erythropoietin in rats subjected to ischemia-reperfusion injury: assessment of infarct size with\u00a099m<\/sup>Tc-annexin V.
    \nJ. Nucl. Med.\u00a0<\/i>\u00a049<\/strong>\u00a0(10) 1694-1700 (2008)<\/li>\n
  3. Kuge Y, Kume N, Ishino S, Takai N, Ogawa Y, Mukai T, Minami M, Shiomi M, Saji H.
    \nProminent lectin-like oxidized low density lipoprotein (LDL) receptor-1 (LOX-1) expression in atherosclerotic lesions is associated with tissue factor expression and apoptosis in hypercholesterolemic rabbits.
    \nBiol. Pharm. Bull.<\/i>\u00a031<\/strong>\u00a0(8) 1475-1482 (2008)<\/li>\n
  4. Ono M, Haratake M, Saji H, Nakayama M.
    \nDevelopment of novel \u03b2-amyloid probes based on 3,5-diphenyl-1,2,4-oxadiazole.
    \nBioorg. Med. Chem.<\/i>\u00a016<\/strong>\u00a0(14) 6867-6872 (2008)<\/li>\n
  5. Temma T, Kuge Y, Sano K, Kamihashi J, Obokata N, Kawashima H, Magata Y, Saji H.
    \nPET O-15 cerebral blood flow and metabolism after acute stroke in spontaneously hypertensive rats.
    \nBrain Res.<\/i>\u00a01212\u00a0<\/strong>18-24 (2008)<\/li>\n
  6. Kiyono Y, Sugita T, Ueda M, Kawashima H, Kanegawa N, Kuge Y, Fujibayashi Y, Saji H.
    \nEvaluation of radioiodinated (2S,alphaS)-2-(alpha-(2-iodophenoxy)benzyl)morpholine as a radioligand for imaging of norepinephrine transporter in the heart.
    \nNucl. Med. Biol.<\/i>\u00a035<\/strong>\u00a0(2), 213-218 (2008)<\/li>\n
  7. Saji H.
    \nApplication of radiometallic compounds for medical diagnosis and therapy
    \nYakugaku Zasshi<\/i>\u00a0128<\/i><\/strong>\u00a0(3) 323-332 (2008)\u00a0Review<\/em><\/li>\n
  8. Ueda M, Iida Y, Kitamura Y, Kawashima H, Ogawa M, Magata Y, Saji H.
    \n5-Iodo-A-85380, a specific ligand for alpha 4 beta 2 nicotinic acetylcholine receptors, prevents glutamate neurotoxicity in rat cortical cultured neurons.
    \nBrain Res.<\/i>\u00a01199<\/strong>\u00a046-52 (2008)<\/li>\n
  9. Kotsuma M, Tokui T, Ishizuka-Ozeki T, Honda T, Iwabuchi H, Murai T, Ikeda T, Saji H.
    \nCYP2D6-Mediated metabolism of a novel acyl coenzyme A:cholesterol acyltransferase inhibitor, pactimibe, and its unique plasma metabolite, R-125528.
    \nDrug Metab. Dispos.\u00a0<\/i>36<\/strong>\u00a0(3) 529-534 (2008)<\/li>\n
  10. Takatsuka S, Morita T, Horikiri Y, Yamahara H, Saji, H.
    \nInfluence of various combinations of mucolytic agent and non-ionic surfactant on intestinal absorption of poorly absorbed hydrophilic compounds.
    \nInt. J. Pharm.<\/i>\u00a0349<\/strong>\u00a0(1-2) 94-100 (2008)<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    2008 Ishino S, Mukai T, Kuge Y, Kume N, Ogawa M, Takai N, Kamihashi J, Shiomi M, Minami M, Kita T, Saji H. lec […]<\/p>\n","protected":false},"author":14,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_crdt_document":"","footnotes":""},"class_list":["post-1643","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/1643","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/comments?post=1643"}],"version-history":[{"count":1,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/1643\/revisions"}],"predecessor-version":[{"id":1644,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/1643\/revisions\/1644"}],"wp:attachment":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/media?parent=1643"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}